Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye

Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye

US Patent 7381708 · Granted Jun 3, 2008

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

High concentration alpha-glucosidase compositions for the treatment of Pompe dis2025
Methods of treating breast cancer with tetrahydronaphthalene derivatives as estr2025
Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis 2023
Lipoxin and lipoxin analogue mediated neuroprotection and treatments2022
High concentration alpha-glucosidase compositions for the treatment of Pompe dis2022
Method to predict response to pharmacological chaperone treatment of diseases2021
Plants with modified deoxyhypusine synthase genes2021
Plants with modified deoxyhypusine synthase genes2021
Intranasal stimulation for treatment of meibomian gland disease and blepharitis2021
Method to predict response to pharmacological chaperone treatment of diseases2020
High concentration alpha-glucosidase compositions for the treatment of pompe dis2019
High concentration alpha-glucosidase compositions for the treatment of Pompe dis2018